Arthritis Foundation Legislative Position Statements

Position Statements

step therapy - thumbnail

Step Therapy

More and more insurers require patients to try and fail one or more covered medications before providing the prescribed medication. We support legislation that addresses burdensome use of step therapy, which can restrict access to needed therapies.

prior authorization - thumbnail

Prior Authorization

Some insurance companies require a lengthy process before dispensing specialty drugs, which causes unnecessary delays. We support legislation to streamline prior authorization protocols to limit lengthy delays and frustrations for doctors, patients, and pharmacies.

out-of-pocket costs - thumbnail

Out-Of-Pocket Costs

Many people with arthritis also suffer from other chronic diseases and monthly medication costs can include several kinds of medications, often at specialty tier cost. We support legislation that tackles high out-of-pocket costs for specialty medications.

negative health insurance plan changes

Mid-Year Formulary Changes

We support legislation that prohibits inappropriate formulary changes, which can negatively impact a stable patient's ability to remain on effective therapy.

biosimilars - thumbnail

Biosimilars

We support legislation that ensures patients and providers are notified when an interchangeable biosimilar substitution is made.

formulary transparency - thumbnail

Insurance Plan Transparency

We support legislation that provides formulary transparency in health insurance plans.

narrow networks - thumbnail

Network Adequacy

We support legislation that ensures patients have access to adequate networks of providers.

drug price transparency

Health System Transparency

We support legislation that will result in system-wide transparency, patient representation in decision-making processes, and collaboration in finding shared solutions.